Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 25, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Sepsis AbdominalGastrointestinal DysfunctionTraditional Chinese Medicine
Interventions
DRUG

Fuzheng Tongfu Jiedu prescription (FZTFJD)

"Fuzheng Tongfu Jiedu prescription (FZTFJD), a kind of Traditional Chinese medicine (TCM).Conventional Western medical treatment in accordance with the 2021 International Guidelines for the Management of Sepsis and Septic Shock. . This included treatment and resuscitation begin immediately, administering antimicrobials immediately, hemodynamic management, mechanical ventilation, organ support, nutritional support, and prophylaxis for acute ulcers."

DRUG

Placebo

"Fuzheng Tongfu Jiedu prescription plaebo. Conventional Western medical treatment in accordance with the 2021 International Guidelines for the Management of Sepsis and Septic Shock. . This included treatment and resuscitation begin immediately, administering antimicrobials immediately, hemodynamic management, mechanical ventilation, organ support, nutritional support, and prophylaxis for acute ulcers."

Trial Locations (1)

100700

Ethics Committee of Dongzhimen Hospital, Beijing

All Listed Sponsors
collaborator

Beijing University of Chinese Medicine

OTHER

lead

Dongzhimen Hospital, Beijing

OTHER

NCT06933238 - Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis | Biotech Hunter | Biotech Hunter